Amgen has agreed to acquire worldwide rights to Celgene’s psoriasis drug, Otezla (apremilast), for $13.4 billion in cash in connection with Celgene’s pending $74-billion merger with Bristol-Myers Squibb (BMS). BMS…
Gilead and Galapagos Close $5.0-Billion Research and Development Deal
Gilead Sciences and Galapagos NV, a Mechelen, Belgium-based small-molecule drug company, have closed their previously announced global research and development collaboration agreement in a deal worth more than $5.0 billion.…
Merck & Co. Enters Collaboration with Themis Bioscience for Vaccine Candidates
MSD, known as Merck & Co., Inc. in the U.S. and Canada, has agreed to a collaboration with Themis Biosciences, a developer of therapies for infectious diseases and cancer, for…
Endo International to Reach $10-Million Settlement in Opioid Medications Case
Endo International and its subsidiaries have offered a $10-million settlement in principle to two Ohio counties in connection with pending opioid litigation. The settlement is effective only upon the execution…
Global Pharma Briefs: News from Europe, Asia and the Middle East
A roundup of developments and the latest news from China (Cipla, Jiangsu Acebright, Sun Pharma), Europe (European Medicines Agency, Swissmedic), India (Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Natco Pharma), Israel (Mapi…
The latest news from CDMOs, CMOs, and suppliers featuring news from WuXi Biologics and Berkshire Sterile Manufacturing. Biologics Manufacturing WuXi Biologics Provides Update on Global Mfg Expansions In its first-half…
Novo Nordisk Contests Shareholders’ $1.75-Billion Lawsuit for US Insulin Sales Disclosures
Novo Nordisk reports that a securities lawsuit has been filed against the company in Denmark by a number of shareholders regarding disclosures of sales of the company’s insulin products in…
Bayer Agrees to Sell Animal Health Business to Elanco for $7.6 Billion
Bayer has agreed to sell its animal health business to Elanco Animal Health, the former animal health business of Eli Lilly and Company, for a transaction value of $7.6 billion.…
FDA OKs New Molecular Entities from Roche, AbbVie and Celgene
A roundup of approvals of new molecular entities (NMEs) from the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), featuring NME approvals from Roche, AbbVie,…
Pfizer To Invest an Additional $500 Million in Gene-Therapy Mfg Facility
Pfizer is investing an additional $500 million in the construction of its gene-therapy manufacturing facility in Sanford, North Carolina. Pfizer says this facility will support its continuing investment in gene-therapy…
